Ignite Creation Date:
2025-12-25 @ 3:54 AM
Ignite Modification Date:
2026-01-29 @ 3:40 AM
Study NCT ID:
NCT00947102
Status:
UNKNOWN
Last Update Posted:
2010-01-13
First Post:
2009-07-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Cancer
Sponsor:
Blood Transfusion Centre of Slovenia
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
Gemcitabine1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Primoz Rozman MD, PhD
Old Organization:
Blood Transfusion Centre of Ljubljana
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |